By Ben Butkus

Akonni Biosystems has received a $300,000 grant from the National Institutes of Health to integrate lateral flow strip technology with its PCR array-based respiratory pathogen assay, according to recently published grant information.

The eventual goal of the project, the company said, is to develop an automated point-of-care molecular testing device to identify hypervariable genomes across a panel of more than 30 common respiratory pathogens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.